1. 1696PA randomized, open-label, non-inferiority study comparing the efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B-cell non-Hodgkin lymphomas (B-NHL): AVOID neutropenia. (23rd October 2018) Authors: Link, H; Illerhaus, G; Martens, U M; Salar, A; Depenbusch, R; Kohler, A; Engelhardt, M M; Mahlmann, S; Zaiss, M; Lammerich, A; Bias, P; Buchner, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTLA-4 directly inhibits osteoclast formation. Issue 11 (18th January 2008) Authors: Axmann, R; Herman, S; Zaiss, M; Franz, S; Polzer, K; Zwerina, J; Herrmann, M; Smolen, J; Schett, G Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 11(2008) Page Start: 1603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Regulation of osteoclast differentiation and function by BiP. (9th March 2010) Authors: Zaiss, M; McGowan, N; David, J-P; Grigoriadis, A; Schett, G; Panayi, G; Corrigall, V Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗